DOI: http://dx.doi.org/10.18203/2349-3933.ijam20180979

Impact of CD4 count in the development of mycobacterium tuberculosis in patients with HIV infection in a tertiary care centre

Satyanarayan T. B., Manjunath M. P., Ranganath M., Mahendra M.

Abstract


Background: Patients with Human Immunodeficiency Virus (HIV) infection are predisposed to numerous opportunistic infections due to decreased cell mediated immunity, Tuberculosis being most common. Low CD4 count is associated with low immunity and higher risk of tuberculosis.

Methods: Author conducted a retrospective study in the department of Pulmonary medicine in a tertiary care teaching hospital during January to December 2017. Author collected data of all the patients with HIV diagnosed with Tuberculosis from the ART centre. Author collected demographic details including age, sex, symptoms at presentation, details of diagnosis of TB including type of tuberculosis, CBNAAT results, CD4 count at the diagnosis of TB, details of ART therapy and ATT therapy and outcomes of treatment.

Results: Eighty one patients with HIV-TB co- infection were included in the study. Males (70.37%) were more affected than females. Mean age of the study group was 39.97±10 years. Sixty one patients (75.4%) were diagnosed with Pulmonary Tuberculosis and 20 (24.6%) patients were diagnosed with extra pulmonary TB. Mean CD4 counts of the cohort was 226±110/µl. Eighty percent of patients developed Tuberculosis with CD4 count <250/µl.

Conclusions: Author found in this study higher proportions of tuberculosis (80.2%) in patients with HIV infection with CD4 count <200/µl. Author also found higher proportion of pulmonary Koch’s in patients with low CD4 count (CD4 <200/µl).


Keywords


Coinfection, CD4 count, HIV-TB, Pulmonary TB

Full Text:

PDF

References


National AIDS Control Organization. HIV Facts and Figures. Available at http://naco.gov.in/hiv-facts-figures. Accessed on Feb 15, 2018.

National AIDS Control Organization. Search Result. Available at http://naco.gov.in/goisearch?search_ key=risk+of+Tb+in+HIV+. Accessed Feb 15, 2018.

Swaminathan S, Ramachandran R, Baskaran G, Paramasivan CN, Ramanathan U, Venkatesan P, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2000;4(9):839-44.

WHO. Tuberculosis and HIV. Available at http://www.who.int/hiv/topics/tb/en/. Accessed on 2 Feb 15, 2018.

Arora D, Jindal N, Bansal R, Arora S. Rapid Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert Assay: A Clinical Study. J Clin Diagn Res JCDR. 2015;9(5):DC03-DC05.

WHO. IRIS: Global tuberculosis control: WHO report, 2011. Available at http://apps.who.int/iris /handle/10665/44728. Accessed on Feb 15, 2018.

Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis and treatment of tuberculosis in HIV co-infected patients. Indian J Med Res. 2011;134(6):850-65.

AIDS info. CD4 T lymphocyte definition. Available at https://aidsinfo.nih.gov/understanding-hiv-aids /glossary/113/cd4-t-lymphocyte. Accessed on Feb 15, 2018.

Wilen CB, Tilton JC, Doms RW. HIV: Cell Binding and Entry. Cold Spring Harb Perspect Med. 2012;2(8).

Jaryal A, Raina R, Sarkar M, Sharma A. Manifestations of tuberculosis in HIV/AIDS patients and its relationship with CD4 count. Lung India Off Organ Indian Chest Soc. 2011;28(4):263-6.

Ackah AN, Digbeu H, Daillo K, Greenberg AE, Coulibaly D, Coulibaly IM, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet. 1995;345(8950):607-10.

Gupta RK, Lawn SD, Bekker L-G, Caldwell J, Kaplan R, Wood R. Impact of HIV and CD4 count on tuberculosis diagnosis: analysis of citywide data from Cape Town, South Africa. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2013;17(8):1014-22.